These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13753230)

  • 1. Lysogeny in a subculture of plague vaccine strain. EV (Girard and Robic).
    KOROBKOVA YI; PAVLOVA LP
    J Hyg Epidemiol Microbiol Immunol; 1960; 4():321-6. PubMed ID: 13753230
    [No Abstract]   [Full Text] [Related]  

  • 2. [IMMUNITY IN PLAGUE. ACQUISITIONS SUPPLIED BY 30 YEARS OF WORK ON THE "PASTEURELLA PESTIS EV" (GIRARD AND ROBIC) STRAIN].
    GIRARD G
    Biol Med (Paris); 1963; 52():631-731. PubMed ID: 14095162
    [No Abstract]   [Full Text] [Related]  

  • 3. [Remarks on a strain of Pasteurella pestis, isolated from a horse in the Belgian Congo; its close connection to the EV strain (Girard and Robic)].
    GIRARD G
    Bull Soc Pathol Exot Filiales; 1957; 50(3):346-50. PubMed ID: 13479743
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lysogeny by phages specific to Yersinia pestis in bacteria of the microbiocenoses of wild plague-carrying rodents].
    Dorozhko OV; Zhuravlev IIa; Rotshil'd EV; Kondrashin IuI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):38-46. PubMed ID: 6449813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microscopic study of the crystalline products of Pasteurella pestis EV strain (Girard and Robic)].
    MANIGAULT P
    C R Seances Soc Biol Fil; 1959; 153(2):279-80. PubMed ID: 13663425
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of Pasteurella pestis bacteriophage on Pasteurella, Salmonella, and Shigella.
    LAZARUS AS; GUNNISON JB
    J Bacteriol; 1947 Jul; 54(1):70. PubMed ID: 20255166
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of a bacteriophage-infected strain of Pasteurella pestis isolated from a human case of plague.
    Harrison DN; Cavanaugh DC; Rust JH; Marshall JD
    Infect Immun; 1971 Jul; 4(1):85-7. PubMed ID: 5154877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of guinea pig lungs to in vivo and in vitro cultures of Pasteurella pestis.
    FUKUI GM; LAWTON WD; JANSSEN WA; SURGALLA MJ
    J Infect Dis; 1957; 100(1):103-7. PubMed ID: 13416642
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta.
    Tian G; Qi Z; Qiu Y; Wu X; Zhang Q; Yang X; Xin Y; He J; Bi Y; Wang Q; Zhou J; Fan Y; Zhou Y; Jiang Y; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(12):3552-60. PubMed ID: 25483697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphological structure of Yersinia pestis populations (strain EV) in the process of live plague vaccine production].
    Cherniad'ev AV
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):43-7. PubMed ID: 15636139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pasteurella pestis lysogeny].
    Larina VS
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):23-6. PubMed ID: 5511382
    [No Abstract]   [Full Text] [Related]  

  • 13. Potency of killed plague vaccines prepared from avirulent Yersinia pestis.
    Williams JE; Altieri PL; Berman S; Lowenthal JP; Cavanaugh DC
    Bull World Health Organ; 1980; 58(5):753-6. PubMed ID: 6975184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE BIOLOGICAL CHARACTERISTICS OF PLAGUE BACTERIOPHAGES].
    ERSHOV FI; BYKOVA ZA
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Apr; 40():131-6. PubMed ID: 14072280
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of Live Plague Vaccine Candidates.
    Feodorova VA; Sayapina LV; Motin VL
    Methods Mol Biol; 2016; 1403():487-98. PubMed ID: 27076149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on immunization against plague. VI. Growth of pasteurella pestis and the production of the envelope and other soluble antigens in a casein hydrolyzate mineral glucose medium.
    ENGELSBERG E; LEVY JB
    J Bacteriol; 1954 Apr; 67(4):438-49. PubMed ID: 13152055
    [No Abstract]   [Full Text] [Related]  

  • 17. [50th anniversary of the EV antiplague vaccine (Girard and Robic)].
    Coulanges P
    Bull Soc Pathol Exot Filiales; 1983; 76(2):114-20. PubMed ID: 6347412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Some data on the cultivation of plague bacteria on synthetic media].
    DOMORADSKII IV; IVANOV VA
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Feb; 28(2):54-9. PubMed ID: 13423810
    [No Abstract]   [Full Text] [Related]  

  • 19. [BIOLOGICAL PROPERTIES OF PLAGUE BACTERIOPHAGES].
    SHASHAEV MA
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Dec; 41():32-5. PubMed ID: 14333939
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDY OF PLAGUE PHAGES AND OF RESISTANCE TO THEM OF BACTERIAL MUTANTS. I. BIOLOGICAL PROPERTIES OF PLAGUE PHAGES].
    VOLOSIVETS AI
    Biull Eksp Biol Med; 1963 Sep; 56():81-4. PubMed ID: 14124790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.